In an editorial, in Oncoscience titled 'Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy,' researcher Ioannis A.
Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy retrieved 13 May 2024 from https://medicalxpress.com/news/2024-05-therapeutic-opportunities-hypermutated-urothelial-carcinomas.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Oct 23, 2023Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Expanding treatment horizons for hypermutated urothelial carcinomas beyond immunotherapyA new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, 'Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy.'
Read more »
Novel therapeutic bispecific antibodies for B-cell lymphomaA new research paper was published in Oncotarget entitled, 'Novel therapeutic bispecific antibodies for B-cell lymphoma targeting IgM and other antigens on the B-cell surface.'
Read more »
Researchers discover new therapeutic target for non-small cell lung cancerNon-small cell lung cancer accounts for nearly 85% of all lung cancer cases. Targeted immunotherapy is a common treatment, but it does not work for everyone.
Read more »
Study of cancer-induced liver inflammation finds a promising therapeutic targetLiver inflammation, a common side-effect of cancers elsewhere in the body, has long been associated with worse cancer outcomes and more recently associated with poor response to immunotherapy. Now, a team led by researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania has found a big reason why.
Read more »
A new therapeutic target for traumatic brain injuryFor the roughly 1.5 million Americans per year who survive a traumatic brain injury, health outcomes vary widely. Not only can these injuries lead to a loss of coordination, depression, impulsivity, and difficulty concentrating, but they come with an amplified risk of developing dementia in the future.
Read more »
The vital role of therapeutic alliances in psychedelic treatmentDrug effects have dominated the national conversation about psychedelics for medical treatment, but a new study suggests that when it comes to reducing depression with psychedelic-assisted therapy, what matters most is a strong relationship between the therapist and study participant.
Read more »